Foscavir is the brand name for foscarnet sodium.  Foscarnet exerts its antiviral activity by a selectively inhibiting the pyrophosphate binding site on virus-specific DNA polymerases at concentrations that do not affect cellular DNA polymerases. It does not require activation by thymidine kinase or other kinases.

Foscarnet is indicated for the treatment of:

1. CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). The combination of foscarnet and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. Safety and efficacy of foscavir have not been established for treatment of other CMV infections (e.g., pneumonitis, gastroenteritis); congenital or neonatal CMV disease; or nonimmunocompromised individuals. 
2. Acyclovir-resistant mucocutaneous hsv infections in immunocompromised patients. Safety and efficacy of foscarnet have not been established for treatment of other HSV infections (e.g., retinitis, encephalitis); congenital or neonatal HSV disease; or HSV in nonimmunocompromised individuals. 

Adverse reactions of this medicine primarily include renal impairment, mineral and electrolyte abnormalities, seizures, hypersensitivity, QT prolongation. Insufficient  well-controlled studies of foscavir is not done in pregnant women. There is potential for serious adverse events in nursing infants, and hence a decision should be made considering the importance of the drug to the mother. The safety and effectiveness of foscavir in pediatric patients have not been established. Since deposition in human bone has also been shown to occur, it is likely that it does so to a greater degree in developing bone in pediatric patients. No studies regarding efficacy or safety of foscavir in geriatric patients, however consistent patterns in adverse reactions seen across all age groups. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Elderly patients are at higher chance of having impaired renal function, care should be taken in dose selection, with monitoring of  renal function.

Pricing and availability: 

Foscarnet is not registered in India and is not readily available through local pharmacies or standard distribution networks.

Since this is a prescription-only therapy, the price quotation for Foscavir is provided upon request, after submission of valid medical documents. For updated pricing and procurement details, contact us. 

The price of foscarnet in India may vary depending on market dynamics, supplier availability, and regulatory updates, since the drug is not registered for commercial sale in India. Cost also depends on supplier, origin country, shipping and documentation. For the most accurate and updated pricing in India, patients can contact us directly.
Pricing may also fluctuate due to GST/local taxes, exchange rates, and changes in company pricing policies.

We help patients buy foscarnet India safely and legally, ensuring full regulatory compliance under the Named Patient Supply (NPS) program and providing assistance throughout the process—from document verification to final delivery.

Access: 

As foscarnet is not commercially registered in India, it can only be accessed through the Named Patient Import Program (NPIP). We assist patients with products like foscarnet in India by procuring medicines for patients under the Named Patient Supply (NPS) route.

Foscavir or foscarnet (foscarnet sodium) injection, 24 mg/mL, for intravenous infusion, is supplied in 250 mL glass bottles containing 6000 mg foscarnet sodium (24 mg/mL) as 250 mL bottles, or in cases of 10. 

Import process:

1. Request submission for your medicine
   Patients or caregivers can send a request for the product by sharing prescription details and treatment requirements.
2. Submission of an application (Form 12A)
   Submit an application in Form 12A, along with a valid prescription from a Registered Medical Practitioner (RMP).
3. Verification of documents
   We verify the prescription and supporting medical documents to confirm eligibility for importing the drug in small quantities for personal medical use.
4. Permission to import
   Once approval is granted by the Drugs Controller General (India), the process of importing medicines begins as per the prescription.
5. Sourcing the medicine
   Our sourcing team connects with authorized global suppliers to find the best foscarnet price in India, thus making it convenient to easily import foscarnet in India, and ensure authenticity before finalizing the offer.
6. Delivery of the medicine
   After approval and confirmation, we coordinate logistics and ensure the safe, compliant, and timely delivery of the product to the patient’s location in India.

Documents Require: 

To enable the product’s import to India, patients need to provide:

1. A valid doctor’s prescription specifying the product name, dosage, treatment duration, and diagnosis.
2. Recent medical history and test reports (preferably from the last three months), including those confirming disease. 
3. Government-issued ID proof and proof of residence of the patient.
4. Import permit if applicable.
   

Order is finalized only after submission of a valid prescription and necessary documents. Once the import permit is approved, the licensed supplier arranges shipment of Foscavir from the USA, Canada, Europe, or Australia etc. 

With these steps, patients can import Foscarnet in India safely and legally. We ensure availability across major Indian cities and source only from verified international suppliers to maintain product authenticity and quality. Pricing is fully transparent, and all prescriptions are verified by registered pharmacists before delivery. For assistance with pricing, documentation, or procurement, patients may contact 24/7QualityMeds.com for reliable support and seamless access.